References
1. Valishin D.A. Hemorrhagic fever with renal syndrome in adults: clinical guidelines. Ufa: Publishing House of Bashkir State Medical University of the Ministry of Health of the Russian Federation, 2015: 74 p. (in Russian)
2. Sirotin B.Z. Hemorrhagic fever with renal syndrome. Khabarovsk, 1994: 304 p. (in Russian)
3. Baygil’dina A.A. Modern concepts of the pathogenesis of hemorrhagic fever with renal syndrome. Meditsinskiy vestnik Bashkortostana [Medical Bulletin of Bashkortostan]. 2014; 9 (1): 98–108. (in Russian)
4. Starostina V.I., Valishin D.A., Murzabaeva R.T., Shaykhullina L.R., Galieva A.T. Pathophysiological aspects of the pathogenesis of hemorrhagic fever with renal syndrome. Zabaykal’skiy meditsinskiy zhurnal [Transbaikal Medical Journal]. 2016; (4): 142–50. (in Russian)
5. Dmitriev A.S. Endothelial and renal dysfunction in hemorrhagic fever with renal syndrome: Abstract of Diss.: 14.01.09. Moscow, 2011: 25 p. (in Russian)
6. Mingazova E.M. Modern biomarkers in the monitoring of acute renal injury in hemorrhagic fever with renal syndrome: Abstract of Diss.: 14.01.09, 14.03.10. Saint Petersburg, 2017: 23 p. (in Russian)
7. Latypova G.R., Khunafina D.H., Valishin D.A., Khasanova G.M., Galieva G.A. Homocysteine as a marker of acute kidney and endothelial injury in patients with hemorrhagic fever with renal syndrome. Meditsinskiy vestnik Bashkortostana [Medical Bulletin of Bashkortostan]. 2019; 14 (6): 18–21. (in Russian)
8. Fahmy E.M., Elfayoumy N.M., Abdelalim A.M., Sharaf S.A.-A., Ismail R.Sh., Elshebawy H. Relation of serum levels of homocysteine, vitamin B12 and folate to cognitive functions in multiple sclerosis patients. Int J Neurosci. 2018; 128 (9): 835–41.
9. Serapinas D., Boreikaite E., Bartkeviciute A., Bandzeviciene R., Silkunas M., Bartkeviciene D. The importance of folate, vitamins B6 and B12 for the lowering of homocysteine concentrations for patients with recurrent pregnancy loss and MTHFR mutations. Reprod Toxicol. 2017; 72: 159–63.
10. Syrtlanova G.R. Pathogenetic role of homocysteine in hemorrhagic fever with renal syndrome. Epidemiologiya i infektsionnye bolezni. Aktual’nye voprosy [Epidemiology and Infectious Diseases. Actual Issues]. 2012; (5): 16–8. (in Russian)
11. Dvoyrin V.V., Klimenkov A.A. Methods of controlled clinical trials. Moscow: Meditsina, 1985: 143 p. (in Russian)
12. Rebrova O.Yu. Statistical analysis of medical data. Using of the application package STATISTICA. Moscow: MediaSfera, 2002: 312 p. (in Russian)
13. Yang Z., Wang L., Zhang W., Wang X., Zhou Sh. Plasma homocysteine involved in methylation and expression of thrombomodulin in cerebral infarction. Biochem Biophys Res Commun. 2016; 473 (4): 1218–22.
14. Wu X., Zhang L., Miao Y., Yang J., Wang X., Wang Ch.-Ch., et al. Homocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis. Redox Biol. 2019; 20: 46–59.
15. Karazhanova L.K., Zhunuspekova A.S. Hyperhomocysteinemia as a risk factor for cardiovascular diseases (literature review). Nauka i zdravookhranenie [Science and Healthcare]. 2016; (4): 129–44. (in Russian)
16. Malinovskaya L.B., Selyuk V.M., Voytovich O.I., Kul’chicky B.B. The place of hyperhomocysteinemia in the pathogenesis of atherosclerosis and thrombosis. Serdtse i sosudy [Heart and Blood Vessels]. 2016; (3): 97–103. (in Russian)
17. Moiz B. Homocysteine as a biomarker for thrombosis: what is the learning curve? J Coll Physicians Surg Pak (JCPSP). 2017; 27 (3): 121–22.
18. Perna A.F., Ingrosso D. Homocysteine and chronic kidney disease: an ongoing narrative. J Nephrol. 2019; 32 (5): 673–5. DOI: https://doi.org/10.1007/s40620-019-00622-1.
19. Alekseev A.V., Gil’manov A.Zh., Gatiyatullina R.S., Rakipov I.G. Modern biomarkers of acute kidney injury. Prakticheskaya meditsina [Practical Medicine]. 2014; (3): 22–7. (in Russian)
20. Liu J., Quan J., Li Y., Wu Y., Yang L. Blood homocysteine levels could predict major adverse cardiac events in patients with acute coronary syndrome: a STROBE-compliant observational study. Medicine (Baltimore). 2018; 97 (40): e12626.